NASDAQ: PRVAPrivia Health Group Inc Stock
$22.01+0.16 (+0.73%)
Updated Sep 26, 2023
PRVA Price
$22.01
Fair Value Price
N/A
Market Cap
$2.58B
52 Week Low
$20.64
52 Week High
$36.55
P/E
75.9x
P/B
4.92x
P/S
2.01x
PEG
4.88x
Dividend Yield
N/A
Revenue
$1.51B
Earnings
$34.00M
Gross Margin
10%
Operating Margin
1.01%
Profit Margin
2.3%
Debt to Equity
0.7
Operating Cash Flow
$40M
Beta
1.18
Next Earnings
Nov 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A
PRVA Overview
Privia Health Group, Inc. collaborates with medical groups, health plans, and health systems, providing purpose-built platforms that organize physicians into physician-led primary-care-centric networks. The Privia Platform integrates Privia-developed and third-party applications into a seamless workflow interface that manages all aspects of the provision of healthcare services. Privia Health Group was founded in 2007 and is headquartered in Arlington, VA.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRVA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PRVA ($22.01) is trading above its intrinsic value of $2.80, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PRVA is poor value based on its earnings relative to its share price (75.9x), compared to the US market average (14.06x)
P/E vs Market Valuation
PRVA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more PRVA due diligence checks available for Premium users.
Be the first to know about important PRVA news, forecast changes, insider trades & much more!
PRVA News
Valuation
PRVA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
75.9x
Industry
55.14x
Market
14.06x
PRVA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PRVA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PRVA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.92x
Industry
3.07x
PRVA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PRVA price to earnings growth (PEG)
For valuing profitable companies with growth potential
PRVA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
PRVA's financial health
Profit margin
Revenue
$413.4M
Net Income
$7.3M
Profit Margin
1.8%
PRVA's Earnings (EBIT) of $15.20M... subscribe to Premium to read more.
Interest Coverage Financials
PRVA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$937.6M
Liabilities
$366.3M
Debt to equity
0.7
PRVA's short-term assets ($654.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRVA's short-term assets ($654.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRVA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$7.6M
Investing
-$72.0k
Financing
-$819.0k
PRVA's operating cash flow ($39.52M)... subscribe to Premium to read more.
Debt Coverage Financials
PRVA vs Health Information Service Stocks
Privia Health Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.